Sodium and Dietary Salt in the Body: Blood Pressure, Salt Sensitivity, and WHO Guidelines

Table salt (sodium chloride, NaCl) constitutes the primary exogenous dietary vehicle for sodium. Quantitatively, 1 gram of sodium chloride yields approximately 400 mg of elemental sodium (40% by molecular mass) and 600 mg of chloride.

Human physiology evolved under severe paleolithic sodium scarcity (intake below 0.5–1.0 g salt/day), shaping powerful renal preservation mechanisms. In industrial societies, salt exposure has escalated tenfold, establishing excess sodium as a primary worldwide driver of hypertension and cardiovascular disease.

Hemodynamic and Endothelial Mechanisms: How Sodium Elevates Pressure

Chronic sodium loading elicits several pathophysiological cascades:

1. Intravascular Expansion and Volume Overload: Hypernatremic elevation of plasma osmolality stimulates hypothalamic osmoreceptors, triggering thirst and vasopressin release. The kidneys conserve free water to dilute extracellular sodium, swelling effective circulating volume. Heightened venous return elevates stroke volume and systemic mean arterial pressure.
2. Endothelial Glycocalyx Breakdown and Nitric Oxide (NO) Deficit: High extracellular sodium concentrations mechanically disrupt the endothelial glycocalyx barrier, suppressing endothelial nitric oxide synthase (eNOS) phosphorylation. The resulting impairment in nitric oxide (NO) bioavailability diminishes vasodilation, promoting arteriolar vasoconstriction.
3. Vascular Remodeling and Arterial Stiffness: Sodium retention stimulates intracellular $Ca^{2+}$ entry into vascular smooth muscle cells, increasing baseline peripheral resistance. Chronic mechanical stress damages elastic lamellae in conduit arteries, accelerating pulse wave velocity (PWV) and transmitting damaging pressure pulsations into renal and cerebral microvessels.

The Physiology of Salt Sensitivity

The hemodynamic response to sodium demonstrates substantial genetic and phenotypic variation:

• Salt-Sensitive Individuals: Present in approximately 50% of hypertensive individuals and 25% of normotensive populations. In these subjects, sodium reduction produces marked systolic drops of 5 to 10 mmHg.
• Genetic Architecture: Polymorphisms in the epithelial sodium channel (ENaC), angiotensinogen (AGT), and aldosterone synthase (CYP11B2) impair renal pressure-natriuresis kinetics (the Guytonian equilibrium), forcing higher blood pressure to clear identical sodium loads.
• Salt sensitivity increases markedly with age, metabolic syndrome, insulin resistance, and renal senescence.

WHO Norms, the DASH Strategy, and Hidden Salt

• World Health Organization (WHO) Threshold: Less than 2,000 mg of sodium daily (equivalent to <5 g of table salt, approximately one level teaspoon).
• American Heart Association (AHA) Target: Ideally 1,500 mg daily for hypertensive patients.
• Current Real-World Consumption: Averages 9 to 12 g of salt per day worldwide.
• The "Hidden Salt" Trap (75–80%): The vast bulk of dietary sodium originates not from the shaker, but from processed commercial foods: commercial breads, processed meats, cured cheeses, canned soups, fast food, and savory sauces (soy sauce yields up to 6,000 mg sodium per 100 ml).

Potassium Antagonism and Hazards of Severe Salt Depletion

• The Na:K Ratio and DASH: Potassium is sodium's biological adversary. High potassium intake promotes renal sodium excretion and hyperpolarizes vascular smooth muscle. The DASH diet (rich in fruits, vegetables, and legumes) targets 4,700 mg potassium and 1,500–2,000 mg sodium, matching the efficacy of single-agent antihypertensive pharmacology.
• Risks of Severe Salt Starvation ($<1,000$ mg/day): Extreme unmonitored sodium restriction reflexively activates the RAAS and sympathetic nervous system, increasing circulating renin and noradrenaline.